With a revenue increase of 1.93% in the first quarter 2026, year on year to cumulative value of $9,937 million, Biogen Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,324,987. The productivity of Biogen Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 3 other companies have achieved higher revenue per employee. While Biogen Inc 's total ranking has deteriorated compared to the previous quarter from 75 to 105. Biogen Inc has 7,500 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIIB Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	1.93 %	-7.14 %	2.79 %	7.33 %	6.13 %
Sales per Employee (TTM) $	1,324,987	1,318,747	1,342,120	1,332,933	1,308,853
BIIB's Total Ranking	# 105	# 75	# 178	# 186	# 223
Seq. Revenue Change	8.7 %	-10.07 %	-4.19 %	8.82 %	-0.97 %

BIIB Company Profile >> Back to BIIB Efficiency Comparisons >> Compare BIIB Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 1
Healthcare Sector	# 4
Overall Market	# 105

Revenue per Employee Statistics
High	Average	Low
$ 1,931,640	$ 1,111,509	$ 316,990
(Jun 30 2020)		(Sep. 30, 2005)

Financial Statements
Biogen Inc 's Revenue MRQ	$ 2,478 Millions	Visit BIIB's Income Statement
Biogen Inc 's Revenues TTM	$ 9,937 Millions	Visit BIIB's aggregate revenue growth
What are BIIB's Sales?		Visit BIIB's Sales by Segment

Other Ratios
Biogen Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BIIB's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BIIB's Competitors
Revenue per Employee for BIIB's Suppliers
Revenue per Employee for BIIB's Customers

You may also want to know
BIIB's Sales Growth Rates	BIIB's Pe Price to earnings ratio	BIIB's Receivables Turnover Ratio	BIIB's Stock Quote
BIIB's Net Income Growth Rates	BIIB's Ps Price to Sales ratio	BIIB's Sales per Employee	BIIB's Asset Turnover Ratio
BIIB's Net Margin	BIIB's Pb Price to Book ratio	BIIB's Financial Strength Ratios	BIIB's Dividend Payout Ratio

Date modified: 2026-08-29T17:18:12+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
United Therapeutics Corporation	2,264,142.86	$ 3,169.800 Million	1,400
Elite Pharmaceuticals Inc	2,261,542.74	$ 147.000 Million	65
Anaptysbio Inc	2,234,500.00	$ 232.388 Million	104
Exelixis Inc	2,071,047.08	$ 2,375.491 Million	1,147
Kiniksa Pharmaceuticals International Plc	2,060,232.24	$ 754.045 Million	366
Cormedix Inc	2,040,572.14	$ 389.749 Million	191
Biocryst Pharmaceuticals Inc	2,036,128.74	$ 885.716 Million	435
Eton Pharmaceuticals Inc	1,968,500.00	$ 86.614 Million	44
Assertio Holdings inc	1,927,509.43	$ 102.158 Million	53
Siga Technologies Inc	1,913,809.53	$ 93.777 Million	49
Prestige Consumer Healthcare Inc	1,909,785.96	$ 1,088.578 Million	570
Zevra Therapeutics Inc	1,886,442.62	$ 115.073 Million	61
Incyte Corporation	1,885,028.13	$ 5,361.020 Million	2,844
Privia Health Group Inc	1,832,456.77	$ 2,246.592 Million	1,226
Tg Therapeutics Inc	1,755,260.65	$ 700.349 Million	399
Gilead Sciences Inc	1,749,176.47	$ 29,736.000 Million	17,000
Collegium Pharmaceutical Inc	1,747,635.93	$ 739.250 Million	423
Rigel Pharmaceuticals Inc	1,722,798.85	$ 299.767 Million	174
Alnylam Pharmaceuticals Inc	1,714,769.20	$ 4,286.923 Million	2,500
Atara Biotherapeutics Inc	1,681,428.57	$ 23.540 Million	14
Xenetic Biosciences Inc	1,595,036.50	$ 3.190 Million	2
Soleno Therapeutics Inc	1,565,978.02	$ 285.008 Million	182
Neurocrine Biosciences Inc	1,551,200.00	$ 3,102.400 Million	2,000
Jazz Pharmaceuticals Plc	1,535,863.32	$ 4,438.645 Million	2,890
Mirum Pharmaceuticals Inc	1,531,206.99	$ 569.609 Million	372
Agenus Inc	1,529,209.88	$ 123.866 Million	81
Progyny Inc	1,510,233.64	$ 1,292.760 Million	856
Apellis Pharmaceuticals Inc	1,495,642.76	$ 1,105.280 Million	739
Bristol myers Squibb Company	1,491,753.85	$ 48,482.000 Million	32,500
Fennec Pharmaceuticals Inc	1,457,114.29	$ 50.999 Million	35

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.